Kirsten Axelsen moderates the PhRMA-sponsored panel session titled “Progress or Regress…How does CMS’ Maximum Fair Price Negotiation align with patient-centered evidence assessment in health care decision-making? on HTA system learnings for CMS’ MFP process.
For more information on this event, click here.